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Abstract 
Methylation of cytosine deoxynucleotides (dC5m) is a well-established epigenetic mark, 
but in higher eukaryotes much less is known about modifications affecting other 
deoxynucleotides. Here, we report the detection of N-6-methyl-deoxyadenosine (dA6m) in 
vertebrate DNA, specifically in Xenopus laevis, but also in other species including mouse 
and human. Our methylome analysis reveals that dA6m is widely distributed across the 
eukaryotic genome, is present in different cell types, but commonly depleted from gene 
exons. Thus, direct DNA modifications might be more widespread than previously 
thought.   
More than 60 years ago, it was discovered that cytosine deoxynucleotides could be 
methylated in eukaryotic genomic DNA1. Since then, dC5m has been extensively studied, 
revealing it as a major genetically heritable regulatory modification for gene 
transcription2–4. Up to now, not much is known in higher eukaryotes about modifications 
affecting other deoxynucleotides. In contrast, RNA, a molecule that is built up from 
similar molecules as DNA, is known to have more than 60 modifications in eukaryotes, 
and when including different organisms, the number is greater than 110 (ref. 5).  Due to 
the strong similarity between the DNA and RNA building blocks, we found it surprising 
that higher eukaryotic DNA is not known to be diverse. In order to determine if there are 
other direct DNA modifications, we used dA6m as an example to discover if the higher 
eukaryotic genome is more diverse than previously thought.  
 
Methylation of deoxyadenosines has been identified and is a well-described epigenetic 
feature in bacteria. In these prokaryotes, dA6m is known to regulate various biological 
pathways such as the restriction-modification system, replication, repair, transcription 
and transposition6–11. Two reports, using restriction enzyme digests, suggested that dA6m 
might exist in higher eukaryotes, but no direct evidence or global pattern has ever been 
reported12,13. Other initial analytical approaches to assess the presence of dA6m in higher 
eukaryotes were unsuccessful, possibly because these approaches were constrained by the 
detection limit of 0.1–0.01% of total deoxynucleotides14–16. Only very recently, it was 
reported that dA6m is present in the genome of the algae Chlamydomonas, in the insect 
Drosophila and in the nematode C. elegans17–19. In contrast to that work, we focused on 
higher eukaryotes instead. 
 Here, we report the identification of dA6m in higher eukaryotes, using the same approach 
used by the other reports. However, ours was developed independently, before the recent 
publications concerning this modification were published. In order to determine the 
presence and distribution of dA6m in eukaryotic genomes, we used dot blots, ultra-high 
performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) and 
applied a dA6m enrichment approach. Using an antibody against dA6m (dA6m Ab), we 
carried out DNA immunoprecipitation (DIP) to enrich for genomic DNA fragments 
containing dA6m that allowed us to identify and describe dA6m genome-wide (Fig. 1a). 
Here, we identified dA6m not only in the genomes of the frog X. laevis, but also in all 
genomes we analyzed, such as the mouse M. musculus and human tissues. We showed 
that this mark is widely distributed across the genome, but is depleted in exonic regions, 
and appeared to have a preference for TAGG sites, and possibly contain AG as a core 
motif.  
 
Results  
To identify dA6m in higher eukaryotic genomes, we applied an antibody enrichment 
approach. First, we verified that an antibody reported to bind to methylated adenosines 
could in fact recognize the dA6m modification20. Dot blot experiments and DIP using 
synthetic oligonucleotides confirmed that this Ab indeed recognizes dA6m 
(Supplementary Fig. 1a–c). We then asked if the X. laevis sperm genome contains dA6m. 
To address this, we isolated DNA from different samples and removed all proteins and 
RNA. We performed dot blots with X. laevis sperm genomic DNA and stained with the 
dA6m Ab (Fig. 1b). Importantly, we detected a dA6m signal with the dA6m Ab on X. laevis 
sperm genomic DNA (Fig. 1b and Supplementary Fig. 1d–h). As controls, we used 
bacterial genomes from deoxyadenosine methylase (Dam) positive (Dam+) and negative 
(Dam–) bacteria. We detected dA6m not only in Dam+ bacteria, but also in Dam– bacteria 
(Fig. 1b). The dA6m signal in Dam– bacteria could be explained by the presence of the 
other deoxyadenosine methylase EcoKI, which maintains some level of dA6m in the 
genome even in the absence of Dam21,22.  
 
Genomes of higher eukaryotes contain dA6m 
To further confirm the results from the dot blot screen, genomic DNA was digested into 
its individual nucleosides and analyzed by UHPLC-MS/MS (Fig. 1a). As a positive 
UHPLC-MS/MS reference, we used a synthetic dA6m standard dilution series, as well as a 
water negative control. dA6m was identified in a given sample only when the retention 
time as well as its fragmentation pattern both matched the synthetic dA6m standard. 
Analogous to the dot blot results, dA6m was detected in both Dam+ and Dam– bacteria 
controls. As expected, the level of dA6m differed between these two bacteria. We 
encountered a lower level of dA6m in Dam– bacteria in comparison to Dam+ bacteria. 
Importantly, we did not detect dA6m in our processed negative control, but detected dA6m 
in the processed DNA isolated from eukaryotic tissues (Fig. 1c and Supplementary Fig. 
2a–d). These results substantiate the dot blot approach and strongly support the presence 
of dA6m in the genome of a higher eukaryotic organism. 
 We next tested if the dA6m Ab can in fact enrich for dA6m. We carried out dA6m Ab DIP 
on sheared X. laevis DNA. The DNA recovered from the dA6m Ab DIP was then further 
processed into its individual nucleosides and analyzed by UHPLC-MS/MS. The results 
validated that the dA6m Ab DIP strongly enriches for the low level of dA6m in higher 
eukaryotes, namely 14,152 times under the conditions applied (Fig. 1d–e and 
Supplementary Fig. 2a–c, e–g). To estimate the abundance of dA6m in the higher 
eukaryotic genome, we used the data obtained from the non-enriched dA6m Ab DIP 
samples. Our results show that dA6m is found 1 in 84 dA in Dam+ bacteria (1.19%), 1 in 
4,215 dA in Dam– (0.02%) bacteria and only 1 in 1,172,141 dA (0.00009%) in higher 
eukaryotic samples (Fig. 1f). This corresponds to 27,238 dA6m in Dam+ bacteria, 542 
dA6m in Dam– bacteria and 1,654 dA6m in one X. laevis genome, or 6,616 dA6m in one X. 
laevis tetraploid cell.  
 
To determine if dA6m is only a feature of X. laevis testes or if it is present in other higher 
eukaryotes, we extended our dot blot screen to search for the presence of dA6m in other 
organisms. Our results suggest that dA6m is not only present in various X. laevis tissues, 
but is also found in all higher eukaryotes we tested, such as in D. rerio, M. musculus and 
tissue culture cells derived from mouse and humans (Fig. 1g). We decided to focus our 
studies on X. laevis and used M. musculus to generalize our findings for higher 
eukaryotes.  
 
Few genes are associated with dA6m 
To study the location and distribution of dA6m containing regions across the genome, we 
generated high throughput sequencing libraries (Seq) from dA6m Ab DIP-enriched and 
input fractions (dA6m Ab DIP-Seq and input-Seq, respectively). We analyzed the 
genomes of X. laevis testes, fat and oviduct, and of M. musculus kidney by dA6m Ab DIP-
Seq (Fig. 2a–d, Supplementary Table 1). For all X. laevis tissues, we processed 2 
biological replicates that were obtained from different animals. In the case of M. 
musculus, we used 3 biological replicates that were also isolated from different animals. 
We compared the dA6m Ab DIP-Seq to the corresponding input-Seq controls in order to 
determine which regions in the genome were enriched by the dA6m Ab, hence, contained 
the dA6m mark. Based on our dA6m Ab DIP-Seq data, we identified in total 27,374 dA6m 
peaks in X. laevis testes, 20,160 in oviduct, 47,834 in fat, and 27,374 in M. musculus 
kidney (Fig. 2d, Supplementary Table 2). In dA6m Ab DIP-Seq experiments, dA6m peaks 
obtained from different cell types add up, aberrantly increasing the total abundance of 
dA6m. Therefore, such peak data should be used only to estimate the distribution of dA6m 
genome wide, rather than to determine the absolute levels of dA6m in the tissue. To 
determine if our sequencing data is of good quality for subsequent genome-wide analyses, 
we determined if it is consistent and reproducible. 
 
By comparing samples to each other using the Pearson Correlation Coefficient and scatter 
plots, we showed that biological replicates (tissues from different animals) as well as 
experimental conditions such as pulldown and input correlate with each other more than 
between different experimental conditions or between different biological sources, 
corroborating the robustness of our sequencing data (Fig. 2b–c). Further, we determined 
the number of identified dA6m peaks in individual replicates, and asked how many of 
these peaks overlap between biological replicates (Fig. 2d). First, the number of peaks 
identified in biological replicates is similar, which supports reproducibility (Fig. 2d). 
Second, the overlap between all biological replicates (tissues from different animals) is 
much higher than one would expect at random (χ2-test, **P-value < 1 × 10–16), 
strengthening the reproducibility of our approach. Next, we determined the overlap of 
dA6m peaks between different tissues (Fig. 2d). We took the overlapping peaks between 
replicates of X. laevis testes, oviduct and fat, and overlapped them between the different 
tissues. We found that some of them overlapped between all tissues, suggesting that some 
dA6m peaks are present at the same location in the genome, irrespective of tissue type. 
This is in particular true for X. laevis oviduct, where 85% of the dA6m peaks identified 
seem to also be present in at least one of other tissues analyzed, namely fat and testes (Fig. 
2d). However, many dA6m peaks seem also to be tissue type specific. For example, 52% 
(7,207) of all dA6m peaks identified in fat are only found in X. laevis fat, while the 
remainder 48% (6,620) are also present in testes, in oviduct or in both (Fig. 2d). Overall, 
we conclude that some of the dA6m peaks are the same in different cell types, but many 
are different, indicating some degree of cell type specificity.  
 
dA6m is predominantly excluded from coding regions 
Despite the high number of dA6m peaks identified, only a small fraction of all genes have 
a dA6m peak. This was observed in all tissues and in samples from both X. laevis and M. 
musculus. Between 6.7% and 20.6% of all genes have a dA6m peak, while the rest of the 
peaks lie in non-genic regions (Supplementary Table 3). In X. laevis, the few genes that 
are found to be associated with dA6m are strongly linked to pathways such as nucleic acid 
binding, metabolic processes and transcription, as determined by gene ontology analysis. 
This was found across all tissues (Supplementary Table 4). In contrast, the genes that are 
associated with dA6m in M. musculus kidney are linked to different pathways, for 
example to ion channel activity, cell adhesion and ATP binding (Supplementary Table 4). 
The different pathways found in M. musculus could either indicate a tissue specific role 
of dA6m in kidney, or be due to the possibility that dA6m regulates different pathways in 
M. musculus than it does in X. laevis. When we analyzed the gene regions further, we 
observed that few dA6m peaks are located in exonic regions. Only 0.1–0.6% of all exons 
have dA6m peaks. In contrast, dA6m peaks are more frequent within introns. We found that 
6.4–17.6% of all genes have dA6m peaks in introns (Supplementary Table 3). This lack of 
dA6m in exonic regions is in accordance with transcriptional start site (TSS) plots (Fig. 3a, 
Supplementary Figure 3a). The TSS plots showed a strong decrease of dA6m levels just 
after the TSS of genes. In addition, occasionally, a small increased abundance of dA6m 
upstream of TSS was detected, in comparison to the more downstream 3’ region. This 
TSS plot pattern, where a strong decrease of dA6m level is observed just after the TSS, 
was encountered in all X. laevis tissues analyzed and also in all M. musculus kidney 
samples (Fig. 3a, Supplementary Figure 3a). This suggests that the absence of dA6m in 
coding regions might be a general feature of dA6m in higher eukaryotes. 
 To obtain a better understanding of the dA6m distribution, we further analyzed the 
abundance of dA6m in the vicinity of genes. We divided regions that are in the vicinity of 
genes into different groups, for example those consisting of 1kb areas upstream and 
downstream of coding genes, and those that distinguish exons and introns. We next 
determined the ratio of methylated versus non-methylated deoxyadenosines in these 
regions, based on our DIP-Seq data. As a control, we also analyzed the dC5m distribution 
in the same way23. Our analysis revealed an enrichment of dC5m in exons (Fig. 3b), but in 
contrast to this we observed depletion of dA6m marks in exonic regions in all X. laevis 
testes replicates (Fig. 3c, Supplementary Fig. 3b). Further, this observation was 
confirmed in all X. laevis and M. musculus tissues analyzed, and in all replicates 
(Supplementary Fig. 3c–e). This suggests that depletion of dA6m in exonic regions is a 
distinct feature of this epigenetic modification. 
 
To further corroborate our findings, we carried out DIP-Seq on X. laevis testes with 2 
other antibodies that are known to recognize dA6m. These are referred to as dA6m Ab* and 
dA6m Ab**. Importantly, dA6m signals identified were irrespective of the antibody used, 
excluding an antibody bias. As a control, we used the corresponding input, but also IgG 
for further validations (Fig. 4, Supplementary Fig. 4, Supplementary Table 1, 
Supplementary Table 5). Our analysis showed that irrespective of the dA6m recognizing 
antibody used, and independently of whether we compared our dA6m recognizing 
antibodies to input or IgG controls, the distribution of dA6m remained the same 
(Supplementary Fig. 4). In all cases we found that the level of dA6m decreased in exons, 
strengthening our previous dA6m DIP-Seq results. 
 
Next, we asked if our dA6m peaks are conserved. For this purpose, PhyloP scores across 
30 vertebrate species were compared to our dA6m M. musculus data24. This analysis was 
not possible for X. laevis, as PhyloP data is not available for this species. Using the Top 
300 dA6m peak overlaps between the kidney M. musculus replicates, we found that the 
conservation score means of dA6m enriched regions (0.08) are smaller than and differ 
significantly (**P-value < 2.2 × 10–16) from the scores when the dA6m enriched regions 
were shifted by 10kb (0.12). This suggested that although there is some conservation, it 
was relatively weak. Bearing in mind that most of our peaks were excluded from coding 
regions, which were considered conserved, it is not too surprising that the dA6m peak 
regions showed weak conservation. This in fact confirmed our previous observations.  
 
“AG” could be a putative consensus site for dA6m 
We then wanted to identify putative dA6m consensus sequence motifs. To verify our 
approach, we first tested the abundance of any 4bp motifs in bacteria. We have carried 
out dA6m Ab DIP-Seq and input-Seq experiments on Dam+ and Dam– E. coli genomes 
and identified dA6m peaks (Supplementary Table 6). We then asked how abundant any 
4bp motif is in these peaks. Out of the 256 possible combinations, we found enrichment 
for the GATC sequence in the dA6m peaks of Dam+ bacteria (Fig. 5a). Importantly, this 
GATC sequence is the known target recognition sequence of the Dam methylase25. In 
Dam– bacteria, this GATC motif, as expected, is no longer the most abundant motif 
encountered in dA6m peaks (Fig. 5a–b). We also applied the MEME prediction program 
to the bacterial dA6m peaks that were at least enriched by a magnitude of 2 (ref. 26). This 
analysis confirmed the GATC Dam motif in Dam+, but not in Dam– bacteria (Fig. 5c). 
This further confirmed the validity of our data and approach to predict the consensus 
sequence of dA6m. Next, we tried to identify potential dA6m consensus sequences for all 
our X. laevis and M. musculus samples. Using MEME, we obtained significant putative 
8bp consensus motifs for all X. laevis tissues (**E-value < 1.2 × 10–8) (Fig. 5d). Also, 
forcing a shift of dA6m peaks by 5kb led to an inability of MEME to identify these 
sequences, showing that these putative motifs were not identified at random 
(Supplementary Fig. 5). Our analysis was not successful on M. musculus, as it seemed to 
be embedded in sequences that are repetitive. This made it impossible to reliably predict 
a motif in M. musculus, even when we tried to remove repeats from the input sequences 
for MEME analysis. As a result, we decided to focus on X. laevis. Interestingly, 
overlapping all of the tissues gives the putative dA6m 8bp motif TAGGAAGG (**E-value 
< 6.7 × 10–141) (Fig. 5d). This sequence was very similar to the ones identified in 
individual tissues, suggesting that this might be or contain a basic motif that is present in 
all tissue types. The sequences found by MEME in different tissues were variable enough 
to make us believe that the core motif was shorter. To determine if we can narrow down 
the 8bp putative motif to 4bp, we determined, as we have done with bacteria, how 
abundant any 4bp motif is in our peaks. However, out of the 256 possible combinations, 
not all are feasible as a potential motif, as the putative motif should at least in part 
overlap with the 8bp motif that was generated with MEME and has to contain a 
deoxyadenosine26. We calculated the frequency of all 256 possible 4bp in the peaks, and 
the noise, namely the frequency one would expect under those peaks when they were 
shifted (Supplementary Table 7). The ratio of those revealed that TAGG is likely to be a 
potential motif, as it is in top 4 most enriched sequences in all overlapped peaks. The 
other most enriched sequences are not applicable, as they are not found by MEME to be 
statistically significant (E-value > 0.05). Interestingly, we did not identify the bacterial 
motif GATC, also confirming we did not have bacterial contamination in our eukaryotic 
datasets. Although MEME and our 4 base predictions showed that the TAGG sequence is 
enriched under our peaks, we are hesitant to claim this is a consensus motif. However, all 
our results point towards part of it being a consensus. We therefore postulate that AG, 
with the major fraction being TAG, forms part of the motif. However, further elaborate 
experimental evidence is required to determine if TAG or AG is in fact a bona fide 
consensus motif in which dA6m is found.  
 
Discussion 
Epigenetic modifications can cause changes to the genome without altering the DNA 
sequence.  These are known to occur on histones, RNA and DNA. Most of the epigenetic 
modifications studied to date are those of histone and RNA modifications. Both 
molecules can bind to specific DNA sequences and subsequently change the accessibility 
of that region, but do not directly modify the DNA itself. Up to date, only dC5m has been 
studied extensively in higher eukaryotes, which directly affects the DNA itself2–4. 
Although intermediate forms of dC5m, such as 5-formylcytosine and 5-carboxylcytosine 
have been discovered and are increasingly being studied, not much is known in higher 
eukaryotes about modifications affecting other deoxynucleotides27,28. We found it 
surprising that so little attention has been given to direct epigenetic modifications. In 
order to determine if there are in fact no other modifications, we used dA6m as an 
example and discovered that the higher eukaryotic genome is more diverse than 
previously thought.  
 
dA6m is a modification found in bacterial DNA and affects gene expression and 
virulence6,10.  However, its presence in higher eukaryotes has been debated12,13. Its 
identification was likely constrained by the low abundance of this modification14–16. With 
technological advancements, the detection limits improved, allowing us to directly 
identify dA6m in the genome of higher eukaryotes. Very recently, other reports were 
published making observations similar to ours, using the same approach17–19. However, 
ours was developed independently, before the recent publications concerning this 
modification were published. We have discovered dA6m in higher eukaryotic organisms, 
while the recent publications reported the presence of dA6m in the genome of the algae 
Chlamydomonas, in the insect Drosophila and in the nematode C. elegans17–19. In 
agreement to previous work, we find that dA6m is a low abundant modification, even less 
abundant in higher eukaryotes than in other organisms. For example, in Drosophila, the 
frequency of the dA6m /dA ratio varies between 0.07–0.001%, in C. elegans between 
0.01–0.4%, and in Chlamydomonas it is 0.4% (refs. 17–19). In the organisms that we 
investigated, dA6m was substantially less abundant, namely 0.00009%. The reason for the 
difference in abundance of dA6m among these organisms is unclear, and may be ascribed 
to inherent differences in genome organization and epigenetic regulators. The high 
abundance of dA6m in C. elegans might also be explained by the fact that these animals 
were fed with Dam– bacteria that still contained dA6m. Indeed, the genome of these 
bacteria still possess residual dA6m due to the presence of the other known 
deoxyadenosine methylase EcoKI, which we have also confirmed by UHPLC-
MS/MS121,22. This might have interfered with the determination of total dA6m levels, as 
well as any functional tests performed in the presence of these bacteria.  
 
When comparing the genome wide distributions of dA6m in M. musculus and X. laevis to 
the other organisms, we encountered a pattern different from what we saw in the in 
higher eukaryotes. Indeed, we found that dA6m is absent from areas downstream of TSS 
and from exons in mouse and frog genomes. In C. elegans, no appreciable distinct pattern 
near genes is observed19. In contrast, in Drosophila and Chlamydomonas genomes, dA6m 
is enriched at or following TSS sites17,18. This is the opposite of what we found in mouse 
and frogs. This different pattern of dA6m suggests that this modification may have distinct 
roles across eukaryotes. However, any functions of dA6m in higher eukaryotes remain to 
be investigated. Key aspects of this investigation are the identification of epigenetic 
modifiers that deposit (methylase) and remove (demethylases) the modification, and of 
possible dA6m interacting proteins. The latter aspect is of particular importance since 
dA6m might serve as a DNA anchor for regulatory proteins to bind, which could then 
trigger various downstream pathways and regulate gene transcription. Also, the presence 
of dA6m could ultimately cause different chromatin landscapes, influence nucleosome 
positioning, or insulate different DNA regions from each other.  
 Overall, our findings suggest that direct epigenetic modifications might be more 
widespread than previously thought in higher eukaryotes. RNA, a molecule that is built 
up from similar molecules as DNA, is known to have more than 60 modifications in 
eukaryotes, and when including different organisms, the number is greater than 110 (ref. 
5).  Due to the strong similarity between the DNA and RNA building blocks, we have 
shown that DNA is much more diverse than has been previously believed. Overall, we 
believe it is very unlikely that DNA is so simplistic while RNA is so diverse. Hence, we 
hypothesize that many of such ‘apegenetic’ (from Greek apeftheias, meaning direct) 
modifications exist. In future, this ‘apegenome’ remains to be discovered and its function 
further investigated. 
  
Accession codes DNA sequencing data has been deposited in the NCBI GEO (Gene 
Expression Omnibus) database with the deposition ID GSE74184. The UHPLC-MS/MS 
data has been deposited in the MetaboLights database with the deposition ID MTBLS276. 
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Figure Legends 
Figure 1. Identification of dA6m in the genome of higher eukaryotes. a, Illustration of 
dA6m identification. dA6m was identified using dot blots, UHPLC-MS/MS and dA6m Ab 
DIP sequencing (DIP-Seq). b, Dot blot with dA6m Ab on DNA templates. c-d, 
Representative (1 out of 4) UHPLC-MS/MS extracted ion chromatogram (EIC) (left) and 
fragmentation spectrum (right) monitoring presence of dA6m in genomic DNA from X. 
laevis. * indicates parent ion, AU=arbitrary units, m/z=mass to charge ratio, n=4 
biological replicates (tissues from different animals). e, Percentage of dA6m versus total 
deoxyadenosines in DNA from different samples following dA6m Ab DIP enrichment. 
Error bars, s.e.m. n=4 tissues from different animals or from independent bacterial cell 
cultures, **P≤0.005, *P≤0.05, two-sided t-test. f, Percentage of dA6m versus total 
deoxyadenosines in DNA from different samples without dA6m Ab DIP enrichment. Error 
bars, s.e.m., n=4 tissues from different animals or from independent bacterial cell cultures, 
**P≤0.005, *P≤0.05, two-sided t-test, but when one sample was zero the one-sided t-test 
was applied. g, dA6m dot-blot of DNA from different higher eukaryotic sources, n=3 
technical replicates. 
  
Figure 2. Genome wide identification of dA6m marks in X. laevis fat, oviduct, testes 
and M. musculus kidney. a, dA6m peak signal tracks. One gene region for each tissue 
type is shown. The y-axis represents the amount of immunoprecipitated DNA at each 
position normalized by the total number of reads. RefSeq gene annotations are shown. 
n=2 for each X. laevis tissue and n=3 for M. musculus, biological replicates from different 
animals, AU=arbitrary units. b, Heat map of Pearson correlation coefficient values from 
comparisons between X. laevis and M. musculus dA6m DIP-Seq and input-Seq samples. 
Correlation was calculated pairwise for all samples, excluding windows where both 
samples in the pair had zero depth. n=2 for each X. laevis tissue and n=3 for M. musculus, 
biological replicates from different animals, **P<1×10–16, Pearson Correlation test on 
mapped reads. c, Scatter plots comparing individual samples pairwise for overlapping 
peaks. The enrichment score ranging from 0–8 is plotted on both axes. The color in each 
plot reflects the correlation value (Pearson correlation coefficient), which is also shown 
in the top right corner of each plot. n=2 for each X. laevis tissue and n=3 for M. musculus, 
biological replicates from different animals, **P<1×10–16, two sided t-test on dA6m peaks. 
d, Number of unique and overlapping dA6m peaks identified in X. laevis and in M. 
musculus tissues. n=2 for each X. laevis tissue and n=3 for M. musculus, biological 
replicates from different animals, **P<1×10–16, χ2-test on dA6m peaks. 
  
Figure 3. Genome wide distribution of dA6m in the vicinity of genes. a, Distribution of 
dA6m peaks around TSS, from 20kb 5’ to 20kb 3’, identified in X. laevis fat, oviduct, 
testes and in M. musculus kidney. One biological replicate from one animal is shown in 
each graph. b, Density of dC5m versus unmethylated dC in distinct areas of the M. 
musculus testes genome. Only the regions shown in dark grey are statistically significant. 
One biological replicate from one animal is shown, **P<0.007, binomial test on dA6m 
peaks. c, Density of dA6m versus unmethylated dA in distinct areas of the genome of X. 
laevis testes. Only the regions shown in dark grey are statistically significant. One 
biological replicate from one animal is shown, *P<0.03, binomial test on dA6m peaks. 
  
Figure 4. Genome wide distribution of dA6m peaks in X. laevis testes samples as 
determined with three different dA6m recognizing antibodies in DIP-Seq and 
comparison to input-Seq or IgG-Seq controls. a, dA6m peak signal tracks. Tracks 
obtained from dA6m Ab DIP-Seq, dA6m Ab* DIP-Seq, dA6m Ab** DIP-Seq and control 
input-Seq and IgG-Seq are shown. One gene region for each biological replicate is shown. 
The y-axis of each profile represents the amount of reads at each position normalized by 
the total number of reads in a given dataset. RefSeq gene annotations are shown. n=2, 
biological replicates from different animals, AU=arbitrary units. b, Heat map of Pearson 
correlation coefficient values from comparisons between X. laevis testes dA6m Ab DIP-
Seq, dA6m Ab* DIP-Seq, dA6m Ab** DIP-Seq, IgG DIP-Seq and input-Seq samples. 
Correlation was calculated pairwise for all samples, excluding windows where both 
samples in the pair had zero depth. n=2,  biological replicates from different animals, 
**P<1×10–16, Pearson Correlation test on mapped reads. c, Scatter plots comparing 
individual samples pairwise for overlapping peaks. The enrichment score ranging from 
0–8 is plotted on both axes. The color in each plot reflects the correlation value (Pearson 
correlation coefficient), which is also shown in the top right corner of each plot. n=2,  
biological replicates from different animals, **P<1×10–16, two sided t-test on dA6m peaks. 
 
  
Figure 5. dA6m motif identification in bacteria and X. laevis.  a, Abundance of 4bp 
motif in dA6m peaks. 256 potential 4bp motifs, each representing one column along x-axis, 
were ranked for their abundance in Dam+ and Dam– bacterial dA6m peaks. The Dam 
recognition motif GATC is shown in red. n=1 biological replicate from one bacterial 
culture for Dam+ and Dam- bacteria, Spearman rank correlation coefficient=0.94 
between Dam+ and Dam– bacteria, Spearman’s **ρ=2.2×10–16. b, Ratio between Dam+ 
and Dam– bacteria enriched 4bp motifs. Only motifs that are at least 5% enriched are 
illustrated. c, Bacterial dA6m motif identified by MEME. In Dam+ bacteria, the motif 
GATC has been identified (73 out of 73 gene regions identified by MEME). n=1 
biological replicate from one bacterial culture for Dam+ and Dam- bacteria, 
AU=arbitrary units. d, X. laevis dA6m motif identification by MEME. Overlaps between 
biological replicates from different animals were used for analysis. Same tissue n=2 
biological replicates from different animals, different tissue overlaps n=6 biological 
replicates for different animals, **E-value<1.2×10–8, statistics by MEME, AU=arbitrary 
units. 
 
 
 
 
 
 
  
 
 
 
Supplementary Table 1. Summary of samples sequenced.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 1. Summary of samples sequenced. X. laevis, M. 
musculus and E. coli bacterial genomes were sequenced using a various number 
of replicates.  IP samples represent Ab pulldown of sonicated, sheared genomic 
DNA. The corresponding input or IgG sample within one biological replicate 
serves as a control for the IP experiment.  
  
Source Sample / biological replicates Mapped Reads (Mil) 
X. laevis testes IP dA6m-rep 1 7.6 
 input-rep 1 16.9 
 IP dA6m Ab*-rep 1 10.5 
 IP dA6m Ab**-rep 1 10.4 
 IP IgG-rep 1 0.4 
 IP dA6m-rep 2 7.8 
 input-rep 2 18.9 
 IP dA6m Ab*-rep 2 9.9 
 IP dA6m Ab**-rep 2 9.9 
 IP IgG-rep 2 0.2 
X. laevis fat IP dA6m-rep 1 17.2 
 input-rep 1 28.3 
 IP dA6m-rep 2 22.8 
 input-rep 2 31.8 
X. laevis oviduct IP dA6m-rep 1 23.5 
 input-rep 1 40.6 
 IP dA6m-rep 2 28.6 
 input-rep 2 33.3 
M. musculus kidney IP dA6m-rep 1 21.1 
 input-rep 1 27.8 
 IP dA6m-rep 2 22.3 
 input-rep 2 26.3 
 IP dA6m-rep 3 36.8 
 input-rep 3 28.1 
E. coli Dam+  IP dA6m-rep 1 1.2 
 input-rep 1 0.2 
E. coli Dam- IP dA6m-rep 1 0.8 
 input-rep 1 0.4 
  
 
 
 
 
 
 
 
 
 
         Supplementary Table 3. Percentage of regions with dA6m peak.  
Presence of dA6m X. laevis 
 
Testes 
X. laevis 
 
Fat 
X. laevis 
 
Oviduct 
M. musculus 
 
Kidney 
Total 
 
 
Gene region with at least one dA6m peak 
(Region: 1kb 5’ to 1kb 3’ of gene including introns) 
 
 
7.6-12.8% 12.5-20.6% 7.5-9.4% 6.7-9.2% 6.7-20.6% 
Genes with at least one dA6m peak in exons 
 
 
0.2-0.5% 0.5-0.6% 0.3% 0.1-0.2% 0.1-0.6% 
Genes with at least one dA6m peak 5kb upstream 
(Region: 0-5kb 5’ to gene) 
2.6-3.9% 4.1-7.6% 2.3-2.8% 1.1-1.8% 1.1-7.6% 
      
Genes with at least one dA6m peak 1kb upstream 
(Region: 0-1kb 5’ to gene) 
0.4-0.7% 0.7-1.3% 0.4-0.5% 0.1% 0.1-1.3% 
      
Genes with at least one dA6m peak 1kb downstream 
(Region: 0-1kb 3’ to gene) 
0.4-0.7% 0.6-1.1% 0.3-0.4% 0.1-0.3% 0.1-1.1% 
      
Genes with at least one dA6m peak in introns 
 
 
Genes with one dA6m peak in introns 
 
6.6-10.9% 
 
 
4.0-8.3% 
10.7-17.6% 
 
 
8.3-12.3% 
 
6.5-8.3% 
 
 
5.5-6.8% 
 
6.4-8.6% 
 
 
4.7-6.0% 
6.4-17.6% 
 
 
4.0-12.3% 
 
Genes with at least two dA6m peaks in introns 
 
 
1.1-2.6% 
 
2.4-5.2% 
 
1.0-1.5% 
 
1.7-2.7% 
 
1.0-5.2% 
 
 
Supplementary Table 3. Percentage of regions with dA6m peak. The 
percentage of dA6m peaks in different regions in and near the vicinity of genes is 
shown for different biological samples. The range of the percentage covers the 
percentage obtained from the biological replicates. 
 
 
 
 
  Supplementary Table 4. Summary of GO term analysis.  
 GO terms Observed/Expected Hits 
(Overrepresented: >1; 
Underrepresented: <1) 
Adjusted 
P-value 
X. laevis  testes  Nucleic acid binding Underrepresented 1.67 x 10-8 
(2 replicate overlap) Nucleobase, nucleoside, nucleotide & nucleic acid metabolic process Underrepresented 7.81 x 10-7 
 RNA binding protein Underrepresented 7.92 x 10-7 
 Binding Underrepresented 5.42 x 10-6 
 Metabolic process Underrepresented 1.02 x 10-5 
 Cell communication Overrepresented 4.57 x 10-5 
 primary metabolic process Underrepresented 5.26 x 10-5 
 RNA binding Underrepresented 1.36 x 10-4 
 Transcription Underrepresented 3.65 x 10-4 
 Signal transduction Overrepresented 3.65 x 10-4 
 DNA binding Underrepresented 2.00 x 10-3 
 Transcription from RNA polymerase II promoter Underrepresented 2.00 x 10-3 
X. laevis fat Nucleic acid binding Underrepresented 4.18 x 10-18 
(2 replicate overlap) Nucleobase, nucleoside, nucleotide & nucleic acid metabolic process Underrepresented 2.24 x 10-13 
 Binding Underrepresented 9.30 x 10-11 
 Metabolic process Underrepresented 9.30 x 10-11 
 Primary metabolic process Underrepresented 1.69 x 10-10 
 RNA binding protein Underrepresented 1.69 x 10-10 
 DNA binding Underrepresented 9.95 x 10-10 
 Transcription Underrepresented 1.63 x 10-8 
 Transcription from RNA polymerase II promoter Underrepresented 9.58 x 10-8 
 Transcription factor activity Underrepresented 1.73 x 10-7 
 Transcription regulator activity Underrepresented 1.73 x 10-7 
 Transcription factor Underrepresented 1.73 x 10-7 
X. laevis oviduct Nucleic acid binding Underrepresented 2.23 x 10-8 
(2 replicate overlap) Nucleobase, nucleoside, nucleotide & nucleic acid metabolic process Underrepresented 4.54 x 10-8 
 Metabolic process Underrepresented 1.24 x 10-7 
 Primary metabolic process Underrepresented 2.03 x 10-7 
 RNA binding protein Underrepresented 1.57 x 17-5 
 Voltage-gated calcium channel activity Overrepresented 1.67 x 10-5 
 Calcium channel Overrepresented 1.67 x 10-5 
 Voltage-gated calcium channel Overrepresented 1.67 x 10-5 
 Transcription Underrepresented 1.92 x 10-5 
 Cell communication Overrepresented 4.36 x 10-5 
 Protein complex Underrepresented 6.11 x 10-5 
 Transcription from RNA polymerase II promoter Underrepresented 6.27 x 10-5 
M. musculus kidney Ion channel activity Overrepresented 6.86 x 10-6 
(3 replicate overlap) Plasma membrane Overrepresented 9.73 x 106 
 Postsynaptic membrane Overrepresented 1.12 x 10-5 
 Membrane Overrepresented 1.85 x 10-5 
 Synapse Overrepresented 2.40 x 10-3 
 Cell adhesion Overrepresented 4.24 x 10-4 
 ATP binding Overrepresented 5.12 x 10-4 
 Synaptosome Overrepresented 9.62 x 10-4 
 Intrinsic to external side of plasma membrane Overrepresented 1.44 x 10-3 
 Ventricular cardiac myofibril development Overrepresented 1.44 x 10-3 
 Cell junction Overrepresented 1.57 x 10-3 
 Extracellular-glutamate-gated ion channel activity Overrepresented 1.79 x 10-3 
Supplementary Table 4. GO terms associated with dA6m peaks in X. laevis. 
Association between dA6m peaks and biological pathways. Adjusted P-value are 
show, GO statistical test. Top 12 hits with lowest adjusted P-values are shown for 
each tissue biological replicate overlap (tissues from different animals).  
Online Methods 
Genomic DNA isolation. All X. laevis and M. musculus tissues were directly isolated 
from sacrificed vertebrates. This was done following all provisions and ethical 
regulations of the Animal (Scientific Procedures) Act 1986, while having licenses and 
approval from the Home Office and the Local Ethical Committee (AWERB). No 
statistical method was used to predetermine sample size. The experiments were not 
randomized and were not performed with blinding to the conditions of the experiments. 
After homogenization of the samples (Precellys 24) and addition of phenol chloroform, 
and the aqueous phase was precipitated with isopropanol and sodium acetate. After 2 
washes with 70% EtOH, the DNA was digested with RNAse A for at least 16hrs at 37°C. 
The DNA was subsequently treated with Proteinase K and purified using the DNeasy 
Blood & Tissue Kit (Qiagen). To ensure removal of any RNAse, the DNA was again 
digested with RNAse A and Proteinase K, and repeatedly extracted with the DNeasy 
Blood & Tissue Kit. The concentration of the genomic DNA was measured using the 
Qubit double stranded High Sensitivity assay kit.  
 
DNA immunoprecipitation (DIP). DNA immunoprecipitation was prepared using the 
protocol from Dominissini et al., with the following variations30: After the isolation of 
genomic DNA, at least 20μg DNA was fractionated into 100–200bp fragments using the 
bioruptor (Diagenode). About 1μg or the fractionated DNA was put aside as an input 
control. The rest of the fragmented genomic DNA was resuspended in a 1ml final 
reaction volume containing 10mM Tris-HCl, 150mM NaCl, 0.1% (v/v) Igepal CA-630 
and 1.5ug/ul BSA. To this, at least 2.5μg of the dA6m Ab (Synaptic Systems GmbH, m6A 
antibody, Cat. No. 202003) was added. Its function was validated as described in Figure 1 
and Supplementary Figure 1. Alternatively, the following antibodies were used: dA6m 
Ab* (Synaptic Systems GmbH, m6A antibody, Cat. No. 202011), dA6m Ab** (Synaptic 
Systems GmbH, m6A antibody, Cat. No. 202111), IgG (Abcam, Cat. No. ab171870). 
Validation of these antibodies is provided on the manufacturer’s website, and has been 
supplemented by our findings in Figure 4. Please note, species specific validation of these 
antibodies is not required as the antibodies were only exposed to DNA, and their target is 
dA6m, which is identical between different species. After an overnight incubation at 4°C 
on a rotor, 100μl of prewashed protein A magnetic beads were added for 2 hrs at 4°C. 
Next, the supernatant was removed while Ab bound to the beads was retained using a 
magnet. After 5 washes with the washing buffer (10mM Tris-HCl, 150mM NaCl, 0.1% 
(v/v) Igepal CA-630), the DNA bound Ab fraction was eluted. For almost all applications, 
the DNA was eluted from the Ab and beads with 150μl of elution buffer that contained 
10mM Tris-HCl, 150mM NaCl, 0.1% (v/v) Igepal CA-630, 6.7mM methylated adenosine 
triphophate). The mixture was then incubated for 1hr with continuous shaking at 37°C. 
The supernatant was removed, and then another 150μl of elution buffer was added to 
remove any unbound remaining fraction. Next, the supernatants were combined, 
precipitated, and used for subsequent analysis.  
 
Dot blot. The desired amount of genomic DNA, in most cases 25ng per sample, was 
diluted in 100μl of 0.5mM EDTA (pH8.0), 7.4% formaldehyde and 6xSSC. Next, the 
samples were incubated for 30min at 60°C, and then kept on ice. A Nylon + membrane 
was soaked in distilled water, and then in 10xSSC. The membrane was transferred into a 
pre-cleaned dot blot filtration apparatus, and was placed on top of 3 Whatman Paper 
sheets. While the apparatus was under vacuum pressure, first, the membrane was 
rehydrated with 10xSSC, and then the DNA containing samples were applied into 
individual wells. After the samples were fully absorbed in the membrane, the wells were 
washed with 10xSSC. The apparatus was dismantled, and the membrane was then 
removed while the apparatus was still under vacuum. After drying in air for about 10min, 
the membrane was crosslinked at 302nm with UV and blocked for 1hr in 5% nonfat dry 
milk and 0.1% PBST (0.1% Tween-20 in 1xPBS, pH7.4). Subsequently, the antibody 
dA6m (Synaptic Systems GmbH) was diluted to 1:1000 in 0.1% PBST and incubated 
overnight at 4°C. Following 3 washes with 0.1% PBST, a fluorescent secondary antibody 
was applied for 30min at room temperature (Alexa Fluor Ab, Invitrogen). After further 3 
washes with 0.1% PBST, the fluorescent signal was visualized and quantified. All 
samples that were processed by dot blots were done in triplicate (technical replicates), as 
well as biological replicates. Original images of blots used presented in the main figures 
can be found in Supplementary Data Set 1.  
 
Dot blot competition experiments. The genomic DNA was applied and cross-linked to 
the membrane as described above. However, the dA6m Ab, used at the same dilution of 
1:1000, was pre-incubated with different competitors and different competitor 
concentrations for 3hrs before being applied onto the sample dotted onto the membrane. 
Dot blots have been cut in order to expose the individual samples to different competitor 
concentrations, but all samples were processed in parallel. The subsequent steps are the 
same as for the normal dot blot procedure described above.  
 
Image analysis. Antibody stained blots were visualized with the LI-COR Odyssey CLx. 
The images were acquired and quantified with the Image Studio Ver 4.0 software. 
 
DNA oligos. Synthetic oligos were used on dot blots and pulldown studies. The sequence 
of the 25bp DNA oligo with no dA6m is 5’ AGTCGTTCATCTAGTTGCGGTGTAC 3’. 
The sequence of the 25bp DNA oligo with dA6m is 5’ AGTCGTTCATCT(dA6m) 
GTTGCGGTGTAC 3’. The sequence of the 110bp DNA oligo with no dA6m is 5’ 
TGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCT
GGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGG
CGATGCC 3’. The sequence of the 110bp DNA oligo with dA6m is 5’ 
TGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCG (dA6m) 
GCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGA
GGGCGATGCC 3’.  
 
Strain genotypes. The Dam– bacteria are a K12 strain, and in addition to lacking the 
Dam methylase, they are also deficient in deoxycytosine methylation (Dcm–). These 
strains were obtained from NEB (dam–/dcm– Competent E.coli), and have been 
authenticated by UHPLC-MS/MS and dot blots (Figure 1, Supplementary Figure 2). The 
genotype is provided on the manufacturer’s website. The Dam+ bacteria are a DH10B 
strain (Invitrogen). The genotype is provided on the manufacturer’s website, and the 
strain has been authenticated by UHPLC-MS/MS and dot blots (Figure 1, Supplementary 
Figure 2).  X. laevis fat and oviduct samples were obtained from female adults. X. laevis 
testes were isolated from adult males. All X. laevis were pigmented, and purchased from 
eNASCO. M. musculus kidneys were obtained directly from adult wild type males, with 
the strain C57B6. All mouse cell lines used in the dot blot experiments come originally 
from the C57B6 strain, have been identified and tested for mycoplasma contamination by 
Q-PCR. The human cell line 293T has been obtained from ATCC (ATCC CRL-3216), 
has been identified and tested for mycoplasma contamination by Q-PCR. 
 
Sample preparation for UHPLC-MS/MS analysis. AGenomic DNA to be analyzed by 
UHPLC-MS/MS was diluted in a volume of 250μl water. Such samples were then 
denatured by heating them at 100°C for 5min and immediately placing them on ice. 20μl 
of 20mM ZnSO4 and 10μl of the nuclease P1 (200units/ml in 30mM sodium acetate, 
pH5.3) were added, in order to digest any DNA strands into individual nucleotides. After 
an overnight incubation at 50°C, 180μl of water, and 1μl of bacterial alkaline phosphatase 
(BAP, 150U/ul) were added. After a 24hr incubation at 37°C, 1ul of the BAP was added 
again, and the samples were incubated at 65°C for another hour. Next, 30μl of 0.5M Tris-
HCl (pH7.9) was added, and the phosphatase reaction was continued for another hour at 
37°C. Next, 400μl of water was added, together with silicic acid that filled the 1.7ml 
Eppendorf tube to about 200μl. After incubation for 15min with occasional vortexing, the 
sample mixture was transferred onto 0.45μm cellulose acetate filters.  After 
centrifugation the silicic acid granules were removed. The flow through was then 
analyzed by UHPLC-MS/MS.  
 
LC-MS/MS analysis. Analysis of global levels of dA and dA6m was performed on a Q 
Exactive Orbitrap mass spectrometer coupled to a Dionex UltiMate 3000 Rapid 
Separation LC fitted with an Acquity UHPLC HSS T3 column (100 x 2.1 mm, 1.8 µm 
particle size). The mobile phase consisted of 0.1% aqueous formic acid (solvent A) and 
0.1% formic acid in acetonitrile (solvent B) at a flow rate of 300 µl/min. Calibration 
curves were generated using serial dilutions of synthetic standards for deoxyadenosine 
(dA, Sigma) and N6-methyl-2’-deoxyadenosine (dA6m, Sigma). The mass spectrometer 
was set in a positive ion mode and operated in parallel reaction monitoring. Ions of 
masses 252.11 (dA) and 266.12 (dA6m) were fragmented and full scans were acquired for 
the base fragments 136.0618 and 150.0774 ± 5ppm (adenine and methyladenine, 
respectively). The EIC of the base fragment was used for quantification. Accurate mass 
of the corresponding base-fragment was extracted using the XCalibur Qual Browser and 
XCalibur Quan Browser software (Thermo Scientific), and used for quantification. 
Quantification was performed by comparison with the corresponding standard curve 
obtained from the pure nucleoside standards running with the same batch of samples. The 
level of dA6m present in the sample was expressed as a percentage of total adenosine 
content (methylated and non-methylated), calculated according to the following equation: 
(%) dA6m = 100 x dA6m /[dA+dA6m]. Differences in dA6m percent abundance were 
considered significant when P ≤ 0.05.  
 
 Illumina sequencing library preparation. High throughput sequencing libraries were 
prepared with different genomic DNA samples following the protocol described by Ford 
et al.29. All libraries were sequenced using Illumina HiSeq 2000 / 2500, single end, 50bp. 
At least two biological replicates (tissues from different animals) were performed for 
each experiment, except for bacterial control samples, where only one replicate was 
carried out. Each experiment consisted of one dA6m DIP and its corresponding input and 
occasionally also IgG sample (Supplementary Table 1). 
 
Bioinformatics analysis. Genome alignment for frog, mouse and bacteria genomes:  
Fastq files were filtered for low quality reads (<Q20) and low quality bases were trimmed 
from the ends of the reads (<Q20).  Bwa 0.6.2 was used to align the resulting reads to the 
appropriate genome31.  Frog data was aligned to the filtered version of the X. laevis 7.1 
Genome32.  Mouse data was aligned to UCSC mm9 except where specified33.  Bacteria 
data was aligned to E. coli K-12 strain MG1655 (ref. 33).  
Annotation and gene set enrichment: X. laevis and M. musculus sequences were 
annotated using InterProScan to provide both InterPro Domains and Panther ontology 
terms34,35.  Descriptions for the remaining NCBI sourced sequences were downloaded 
from the NCBI.  Gene set enrichment was obtained using Panther GO Slim terms (7.2) 
with topGO (Bioconductor package version 2.6.0. 
http://www.bioconductor.org/packages/release/bioc/html/topGo.html). 
 
Peak calling: PCR duplicates were removed from the aligned datasets and peaks were 
called using SICER, comparing dA6m pull-down over input or IgG (parameterisation: 
redundancy threshold = 1, window size = 200, fragment size = 200, effective genome 
fraction = 0.74 (0.89 X. laevis), gap size = 400, FDR = 0.05)36.  
X. laevis genome filtering: Due to the lower quality of this genome assembly, the 
following filtering steps were performed to increase the accuracy of both mapping and 
motif analysis. Repeat masker was used to remove any residual repeats (RepeatModeler 
Open-1.0. 2008-2010 <http://www.repeatmasker.org>). Sequences of low quality 
(represented as lower case) were masked. Uninformative sequences were removed using 
DUST and homopolymers of more than 4 bases were removed37.  
Replicate overlaps: The overlaps between replicate peaks were detected using the R 
bioconductor library “Genomic Features->findOverlaps” (ref. 38). For statistical purposes, 
one set of peaks in each pairwise comparison was randomly redistributed (shuffled) 
around the genome. This was repeated 100 times and the mean number of intersected 
peaks was taken. These shuffled peaks were then compared to the non-shuffled pair 
resulting in the number of overlaps. This number was then compared to the number of 
overlaps generated from the original (both pairs un-shuffled) set of peaks using a χ2-
square test. In all cases, the resulting P-value was less than 10–16.  
Motif analysis with MEME: Motifs were called using MEME on the sequences below the 
peaks26.  For E.coli peaks with at least 2 times enrichment were analyzed, while for larger 
genomes, namely M. musculus and X. laevis, the top 300 enriched peaks were analyzed 
by MEME. For M. musculus the data was mapped to a filtered version of mm9 where 
known uninformative sequences were removed using Repeat Masker (RepeatModeler 
Open-1.0. 2008-2010 <http://www.repeatmasker.org>) for repeats and DUST for regions 
of low complexity37.   
Homopolymers of more than 4 bases were also removed from the genome. For X. laevis 
the filtered genome as described above was used.  MEME was run on the sequences of 
the peaks from overlapping replicates or tissues, and on the sequences of the peaks 
obtained from individual replicates. Statistically significant (E-values < 0.05) 8bp motifs 
were only found in the overlapping data between replicates and tissues, and only in X. 
laevis.  
MEME was run using the ZOOPS model generating different motifs26.  Motifs were then 
called using shifted peaks with the same size and distribution to build a background 
probability of occurrence for the observed motif.  
4bp motif analysis: The frequency of all possible four base pair combinations was 
calculated for sequences of regions under peaks and not under peaks. For all 
combinations, differences between these two frequencies were then ranked by the 
respective ratios. 
TSS plots: The distance to each TSS from the midpoint of all reads within 20 kb of that 
TSS was measured. The distances were pooled over all TSS locations and plotted in a 
histogram with 200 bp bins. 
Scatter plots: For all pairwise intersections of peaks, a scatterplot was generated where 
enrichment values were plotted for each pair of overlapping peaks. Pearson correlations 
were also calculated over all enrichment values and t-tests were performed, yielding 
values less than 10–16 in all cases. 
Conservation analysis: Conservation scores were downloaded from UCSC phyloP 
conservation tracks for mouse (mm9)24. For each base position under a peak the P score 
was taken and the overall score was calculated. For each set of peak calls, a conservation 
score distribution was generated by extracting the phyloP for each position in the peak 
ranges (n>50 in all cases, so Central Limit Theorem applies).  This was compared 
between peaks shifted by 10kb and the original peaks and the original peaks were shown 
by a t-test to have a significantly higher level of conservation (P-value < 2.2 ×10–16 in all 
cases). 
Determination of dA6m peak distribution in gene regions: The midpoint of peak locations 
was classified into regions of the genome including exonic, intronic, intergenic and 
around the TSS and transcriptional termination sites. The data was normalized to 
abundance in genome. The peak counts in these regions were modeled by a Poisson 
distribution assuming, under the null hypothesis, that the incidence rate in each was equal 
to that of the whole genome average. The probability of the observed counts, given this 
distribution, was calculated for each region to ascertain whether peak rates were 
significantly different to the whole genomic background. 
 
Statistical analysis (of dot blots, mass spec and Ab pulldown yield quantifications). 
Statistical differences, P-values, were calculated using the two-sided t-test for paired 
samples. For calculations of P-values between samples in which one sample had only 
zero as values, the one-sided t-test was applied. All experiments were carried out with 3 
technical and biological replicates, indicated by n. All P-values ≤ 0.05 are formatted as 
*P, while all P-values ≤ 0.005 are indicated as **P.  
 
Venn diagrams. Venn diagrams were drawn with the help of eulerAPE v3 (ref. 39).  
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